Effects of ibandronate treatment on bone mass, architecture and strength in the ovariectomized cynomolgus monkey.

被引：0
|
作者：
Smith, SY
Recker, R
Hannan, M
Bauss, F
机构：
[1] ClinTrials BioRes Ltd, Quebec City, PQ, Canada
[2] Creighton Univ, Omaha, NE 68178 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA USA
[4] Roche Diagnost, Mannheim, Germany
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA370
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [41] Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats
    Uyar, Yildiz
    Baytur, Yesim
    Inceboz, Umit
    Demir, Bilge Cetinkaya
    Gumuser, Gul
    Ozbilgin, Kemal
    MATURITAS, 2009, 63 (03) : 261 - 267
  • [42] Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice
    Lei, Tao
    Liang, Zhuowen
    Li, Feijiang
    Tang, Chi
    Xie, Kangning
    Wang, Pan
    Dong, Xu
    Shan, Shuai
    Jiang, Maogang
    Xu, Qiaoling
    Luo, Erping
    Shen, Guanghao
    BONE, 2018, 108 : 10 - 19
  • [43] The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats
    Liu, Xuqiang
    Qu, Xinhua
    Nie, Tao
    Zhai, Zanjing
    Li, Haowei
    Ouyang, Zhengxiao
    Qin, An
    Zhang, Shuhong
    Zhang, Shuangyan
    Fan, Qiming
    Tang, Tingting
    Yu, Zhifeng
    Dai, Min
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [44] Effects of pregnancy and lactation on parameters of maternal bone metabolism in the common marmoset monkey.
    Power, RA
    Jerome, CP
    Bailey, TS
    Power, MP
    Oftedal, OT
    Layne, DG
    Tardif, SD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S274 - S274
  • [45] Denosumab treatment is associated with decreased cortical porosity and increased bone density and strength at the proximal humerus of ovariectomized cynomolgus monkeys
    Haider, Ifaz T.
    Sawatsky, Andrew
    Zhu, Ying
    Page, Rebecca
    Kostenuik, Paul J.
    Boyd, Steven K.
    Edwards, W. Brent
    BONE, 2022, 164
  • [46] Preventive effects of sequential treatment with alendronate and 1α-hydroxyvitamin D3 on bone mass and strength in ovariectomized rats
    Ito, M
    Azuma, Y
    Takagi, H
    Kamimura, T
    Komoriya, K
    Ohta, T
    Kawaguchi, H
    BONE, 2003, 33 (01) : 90 - 99
  • [47] Transition From Alendronate to Denosumab in Ovariectomized Cynomolgus Monkeys Maintained or Improved Cortical and Trabecular Bone Mass, Without Altering the Linear Relationship Between Bone Mass and Bone Strength.
    Ominsky, M. S.
    Smith, S. Y.
    Vlasseros, F.
    Samadfam, R.
    Kostenuik, P. J.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S22 - S22
  • [48] Four week treatment with timolol plus dorzolamide+PGF2α reduces outflow facility in the cynomolgus monkey.
    Kiland, JA
    Gabelt, BT
    Kaufman, PL
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S838 - S838
  • [49] Long Term effect of BA058, a Novel Human PTHrP Analog, Restores Bone Mass in the Aged Osteopenic Ovariectomized Cynomolgus Monkey
    Doyle, Nancy
    Varela, Aurore
    Smith, Susan Y.
    Hattersley, Gary
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [50] Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat
    Kurth, AA
    Kim, SZ
    Sedlmeyer, I
    Bauss, F
    Shea, M
    BONE, 2002, 30 (01) : 300 - 306
12345